Reported on November 28th, according to the documents disclosed by the Hong Kong Stock Exchange on November 28th, Citic Securities Asset Management Co., Ltd. increased their shareholding on November 27th at an average price of 20.6589 Hong Kong dollars per share.$SINOPHARM (01099.HK)$1.7252 million H shares, valued at approximately 35.6407 million Hong Kong dollars. After the shareholding increase, Citic Securities Asset Management Co., Ltd.'s latest total shareholding is 80.5316 million shares, with the good warehouse ratio rising from 5.87% to 6.00%.
This trade involves other related parties: citic sec - Yunfan single asset management plan.
Additional information: The equity is held by citic sec asset management company on behalf of all the asset management plans it manages, disclosing the shares of sinopharm holdings limited - H share equity.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
